UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030398 |
|---|---|
| Receipt number | R000034705 |
| Scientific Title | The prediction of post-operative metastasis using for the ISYNA1 expression analysis in primary renal cancer. |
| Date of disclosure of the study information | 2017/12/21 |
| Last modified on | 2017/12/14 13:39:20 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The prediction of post-operative metastasis using for the ISYNA1 expression analysis in primary renal cancer.
Acronym
The prediction of post-operative metastasis using for the ISYNA1 expression analysis in primary renal cancer.
Scientific Title
The prediction of post-operative metastasis using for the ISYNA1 expression analysis in primary renal cancer.
Scientific Title:Acronym
The prediction of post-operative metastasis using for the ISYNA1 expression analysis in primary renal cancer.
Region
| Japan |
Condition
Condition
Renal cancer
Classification by specialty
| Urology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To examine whether the ISYNA1 expression in primary renal cancer of surgery patients can predict the appearance of post-operative metastasis.
Basic objectives2
Others
Basic objectives -Others
The period until appearance of post-operative metastasis.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The period until appearance of post-operative metastasis.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Study participants were selected from the patient who was operated for renal cancer at the Fukushima Medical University Hospital from November, 2012
Key exclusion criteria
Patient with preoperative metastasis
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoshiyuki Kojima |
Organization
Fukushima Medical University School of Medicine
Division name
Department of Urology
Zip code
Address
1 Hikarigaoka, Fukushima-shi, Fukushima, Japan
TEL
024-543-1316
ykojima@fmu.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Tomoyuki Koguchi |
Organization
Fukushima Medical University School of Medicine
Division name
Department of Urology
Zip code
Address
1 Hikarigaoka, Fukushima-shi, Fukushima, Japan
TEL
024-543-1316
Homepage URL
gucchii@fmu.ac.jp
Sponsor or person
Institute
Department of Urology, Fukushima Medical University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
福島県立医科大学病院（福島県）、太田西ノ内病院（福島県）、竹田綜合病院（福島県）
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 12 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2012 | Year | 11 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 11 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
To examine whether the ISYNA1 expression in primary renal cancer of surgery patients can predict the appearance of post-operative metastasis.
Management information
Registered date
| 2017 | Year | 12 | Month | 14 | Day |
Last modified on
| 2017 | Year | 12 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034705
